Innovation Pharmaceuticals Inc (CE) (IPIX) News

The one question…. LOL. Fuck no. U know that. Shit. Core shares here when I sold just before the release of the COVID results were invested in bitcoin/alt/meme coins. I 10x that and am currently up 5x this bull run which is just getting started. This shit is and will always be chump change compared to crypto.

Poor bastards. Shake that bag.

I still have mine!

The one question that results in silence. Blissful silence.

Hey Hound, as per your old posts, you were a huge investor???? Do you still own your shares?????

While we wait…Any new B-Petri dish papers published lately?

Petri dish studies, also known as in vitro experiments, often lead to false hope because they are conducted in highly controlled laboratory environments that do not fully replicate the complexity of living organisms. Here are the key reasons for this:

1. Oversimplified Conditions
In a Petri dish, cells are isolated and grown in artificial environments with carefully controlled nutrients, pH, and temperature. This does not mimic the intricate systems and interactions that occur in a living organism. A treatment that works on isolated cells may behave very differently in the body.

2. Lack of Systemic Factors
The body is a dynamic system with multiple interacting components, including the immune system, hormones, and metabolism. A treatment might show promise in a Petri dish but fail when introduced to the complexities of a whole organism.

3. Doses and Delivery
In in vitro studies, substances can be applied directly to cells at specific concentrations. In the body, reaching the target cells in the same way can be much more difficult due to issues with absorption, distribution, metabolism, and excretion.

4. Overextrapolation
Positive results in in vitro studies are sometimes overhyped in the media or even by researchers, leading to unrealistic expectations about how soon a discovery might lead to effective treatments for humans.

5. Lack of Whole-Body Toxicity Data
A compound might kill harmful cells in a Petri dish but could be toxic to normal cells or organs in a living organism. The safety profile often cannot be assessed until in vivo studies (in animals or humans) are conducted.

Example

Many cancer drugs have shown promise in killing tumor cells in a Petri dish but fail in clinical trials due to poor efficacy in the body or unacceptable side effects. Similarly, certain antioxidants or supplements that protect cells in in vitro studies have not demonstrated significant health benefits when tested in humans.

Conclusion

While Petri dish studies are valuable for initial insights and screening, they are only the first step in a long process of research. Their findings must be validated through animal studies, human trials, and real-world applications before they can lead to effective and safe treatments.

Universities publish a significant amount of research involving Petri dishes (in vitro studies) because these experiments are foundational to scientific inquiry and serve important purposes in advancing knowledge and innovation. Here’s why:

1. Early-Stage Discovery

• In vitro studies are often the first step in investigating new ideas, testing hypotheses, and identifying potential mechanisms in biology and medicine.

• They provide a cost-effective and controlled way to test theories before advancing to more complex and expensive animal or human studies.

2. Building a Knowledge Base

• Universities prioritize generating fundamental knowledge, even if it doesn’t immediately lead to clinical applications.

• Petri dish studies contribute valuable insights into how cells, molecules, and organisms work at a basic level.

3. Low-Risk and Ethical Feasibility

• Using Petri dishes avoids ethical and logistical complications involved in animal or human studies.

• Early-stage research involving living organisms requires more rigorous oversight and approval, making in vitro studies an accessible starting point.

4. Funding and Academic Metrics

• Grant agencies often fund exploratory research to develop preliminary data for larger projects. Petri dish studies are a common source of this early data.

• Academic researchers are often measured by their publication output, so publishing in vitro findings helps meet performance and funding expectations.

5. Proof of Concept

• Researchers use Petri dish experiments to show whether an idea has potential. These results can justify follow-up studies in animals or humans, securing further funding or collaboration.

• Journals often accept such studies because they are a crucial step in the pipeline of scientific discovery.

6. Incremental Nature of Science

• Science progresses in small, incremental steps. Petri dish studies often represent one of these steps in understanding complex biological phenomena.

• Even if a study doesn’t lead directly to a cure or breakthrough, it may provide a building block for future discoveries.

7. Ease of Reproducibility

• Petri dish studies are typically easier to replicate compared to animal or human studies, making them valuable for establishing reproducible science.

Challenges and Context

While universities publish a lot of Petri dish research, it is essential for scientists, journals, and the media to clearly communicate the limitations of such studies. Misrepresentation of preliminary findings as groundbreaking breakthroughs can lead to false hope, but this is not inherent to the research itself—it’s often a matter of how the results are presented or interpreted.

IPIX has until 1/19 to respond to the Cummings brief filed on 11/12.
Unfortunately we don't get to see what these briefs say.

This is the last hard fact I've seen...from the original case:
"08/23/2024 ORDER: of Post Judgment Security
..II. ALTERNATIVE SECURITY
In accordance with General Laws c. 223, sec. 86A, Innovation shall obtain and provide within thirty (30) days of this Order a bond payment to Cummings with sureties to be approved by this Court conditioned to pay Cummings the amount of at least $1,375,811.36, within thirty (30) days of the date when execution may issue upon judgment, which bond shall be filed with the clerk after its approval by the Court."

Would be interesting to know if that was done....I thought the appeal was contingent on it.

Now delayed until January 19th?

oooooooooooooooooo2 x 0 is zero. It’s dead.

We're holding at .oooooooooooooooooo2.  Not dead yet! 

IPIX is dead. Not trading. Zero value.

4 trillion shares traded TODAY so far. 1/4 Billion dollars. Dump the remaining buck left in your bag and make100x ur money for a $100 steak dinner at Outback! Hell! I’m buyin. Let’s go!

Poor bastards.

LOL. Shake that bag.

I have to admit that I agree with you!!!!!!

"he's due to update his shareholders....."

What a ridiculous comment. Due? He's been OBLIGATED to update his shareholders (and everyone else) since the 10Q that was filed A YEAR AGO yesterday and he hasn't.
He continues to show himself to be irresponsible at the very least....crooked is probably more fitting.

You're lucky you haven't heard from him. It would only add fuel to your misguided beliefs.

I'd rather hear from Leo, he's due to update his shareholders.....

Absolutely, unless it's a quiet period that has been dragging on. I would love to hear from frenchbroad right about now.

That's a great question that only Leo can answer. I really wish he would address his shareholders......

Has or will IPIX be compensated by the... many companies who have included Brilacidin in their patent applications?
Have these companies entered into compensation arrangements or agreements with IPIX?
Can anyone knowledgable in this area enlighten me? TIA

Brilacidin has been included in many patent applications. Have these companies done this after entering into compensation arrangements or agreements with IPIX?
Can anyone knowledgable in this area enlighten me? TIA

Shake that bag.

IPIX isn't dead.

Humanigen published this patent on Sept 26, it mentions Brilacidin 50 times. Perhaps Leo does have something up his sleeve.....

https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/20240317846?requestToken=eyJzdWIiOiIyZmFjYWE1YS1jMWFmLTQ4NjItYmE0ZS00MWFlYjZmODJjMzciLCJ2ZXIiOiI1OWRjOTJlMS0zY2JlLTQxOWEtYjg3Ni1lZDk3ZDZhNWZhOTkiLCJleHAiOjB9

Smart man.

RFK recently said he put the majority of his wealth into bitcoin.

Lots of ink. Lots of zeroes after the decimal point in the Company share price. An absent-without-explanation CEO. And no Current Information.

Hey its the Expert Market Expert, in all seriousness RFK is late to the Brilicidin party,,,, or is he front loading millions in shares of Ipix? Things that make you go Hmmmm

Admit it LR, B has alot of ink on it, that's all you need to answer please

If the objective of these persons is to reduce the Ipix price I will say they have big success. For now there is no reason to use their time and continue work.

I think it is some thing more

Clearly you’re connected to IPIX. Connect the bagholders to Regeneron again please. Pump B. Shine the laser. What’s the share count up to? We’re all overdue for a laugh.

How does entry into the Expert Market fit with the just-like-Regeneron-does-it strategy?

I'll bet the Regeneron shareholders could find their CEO if they needed to.

How's the Regeneron ray gun program going?

LOL. Right on point.

Hahaha.

10Q due today!

Or it would be due if they had filed the two 10Qs and the 10K that they failed to file previously.

Update on the IPIX appeal. Below is from the Appeals Court website:

11/12/2024 #18 Appellee brief filed for Cummings Properties, LLC by Attorney Michael Barker.

IPIX is dead.

Wrap your head around these numbers.

8.7 Trillion today thus far and it’s not even running yet. In fact it just was released today on my platform for trading. Day 1.

Just an FYI....the Cummings response to the IPIX appeal is due today.

Believe you are correct. The other guy probably wanted to change his last name after meeting Leo.

And if I remember correctly no connection could be made between the 2 Ehrlichs. Tried again yesterday with the same result. For that matter the Locust Walk and IPIX relationship came up empty as well.

Here Today Gone Tomorrow
Right back at you ...

In 2019, the loser Ehrlich retained Locust Walk to showcase and maximize Innovation Pharmaceuticals value. A big failure but the legitimate Ehrlich (who must have had a lapse in judgement) was the Locust Walk representative who was referenced in the press release.

http://www.ipharminc.com/press-release/2019/9/30/innovation-pharmaceuticals-engages-locust-walk-a-global-life-sciences-transaction-firm

Hmmmm. Seems to have touched a "small nerve" there huh JT??? Wonder why????

Here Today Hey Einstein here is a suggestion-why don't you give them a call and ask them??

Definitely not his son.....read this:
https://www.kellogg.northwestern.edu/news_articles/profiles/alumni/chris-ehrlich.aspx

This guy's dad died 5-6 years ago.

Hmmmmm.

I'm wondering if this is CEO is Leo's son or otherwise relative????

https://finance.yahoo.com/news/cero-therapeutics-inc-provides-corporate-130000465.html

leavetheguntakethecannolis wishing leavetheipixtaketheshibainu was possible.

Bitcoin’s bull run is underway. Up 5% today, 15% week, 35% month. IPIX isn’t tradable. IPIX shares are worthless.

"If his appeal goes against him, and if he is still alive, bankruptcy will follow."

To be clear, the company will go bankrupt, not Leo "who gives a shit about the SEC" Ehrlich.

He will keep all the many millions of dollars he took from IPIX, including his kickback for transferring $4 million of shareholders' money to an off shore start-up company in a completely unrelated industry.

It's not cheap to maintain a garish mansion in Florida, especially when it's complete with a pool (and a pool boy, natch). Even if you take paying guests, you gotta grift, apparently.

If there was any hope for B, don't you think Rip Van Ehrlich would have woken up from his self-induced coma? Unfortunately, that lying idiot has left his one-man company in shambles with virtually nothing of value remaining. If his appeal goes against him, and if he is still alive, bankruptcy will follow.

This patent was published on 9/26/24 by Humanigen. Brilacidin was mentioned 50 times....
https://ppubs.uspto.gov/dirsearch-public/print/downloadBasicPdf/20240317846?requestToken=eyJzdWIiOiI3Mzk5ZGZhNy02MWUxLTQwNDctYjAyNC04NGI2Njk0ZmY5NGIiLCJ2ZXIiOiI4NjE1YzIzMi01MzFiLTQwM2EtYTUzYi0xNThjZmUwZjExY2UiLCJleHAiOjB9

That’s why ur broke.

I believe so, yes.

https://investorshub.advfn.com/boards/read_msg.aspx?message_id=175290418

Electoral, popular, senate and house. Total control. No more flock blocking. So there’s that too. None of which helps this dead piece of shit.